MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Long Term Debt Summary of MediPharm Labs Corp.

  • MediPharm Labs Corp.'s latest annual long term debt in 2023 was 69 Thousand CAD , up 102.94% from previous year.
  • MediPharm Labs Corp.'s latest quarterly long term debt in 2024 Q2 was 47 Thousand CAD , down 0.0% from previous quarter.
  • MediPharm Labs Corp. reported annual long term debt of 34 Thousand CAD in 2022, down -66.99% from previous year.
  • MediPharm Labs Corp. reported annual long term debt of 103 Thousand CAD in 2021, down -99.04% from previous year.
  • MediPharm Labs Corp. reported quarterly long term debt of 47 Thousand CAD for 2024 Q2, down 0.0% from previous quarter.
  • MediPharm Labs Corp. reported quarterly long term debt of 69 Thousand CAD for 2023 Q4, down -12.66% from previous quarter.

Annual Long Term Debt Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Long Term Debt of MediPharm Labs Corp. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 69 Thousand CAD 102.94%
2022 34 Thousand CAD -66.99%
2021 103 Thousand CAD -99.04%
2020 10.76 Million CAD 22.88%
2019 8.75 Million CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%

Peer Long Term Debt Comparison of MediPharm Labs Corp.

Name Long Term Debt Long Term Debt Difference
Aurora Cannabis Inc. 47.57 Million CAD 99.855%
Avicanna Inc. 95.36 Thousand CAD 27.644%
Avant Brands Inc. 1.74 Million CAD 96.037%
Cardiol Therapeutics Inc. 158.53 Thousand CAD 56.476%
Crescita Therapeutics Inc. 815 Thousand CAD 91.534%
Knight Therapeutics Inc. 44.01 Million CAD 99.843%
OrganiGram Holdings Inc. 79 Thousand CAD 12.658%
Canopy Growth Corporation 493.29 Million CAD 99.986%
Willow Biosciences Inc. 594 Thousand CAD 88.384%
Auxly Cannabis Group Inc. 81.38 Million CAD 99.915%